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Strengths and limitations of this study
 ► Thorough methods of case ascertainment for intel-
lectual disabilities at baseline.
 ► Individual verification of intellectual disabilities and 
its severity, and detailed health assessments at 
baseline.
 ► Longitudinal design.
 ► Large cohort size and study duration, and successful 
record linkage for 94% of participants.
 ► Limitations include that the study was conducted in 
only one part of Scotland, and the reliance on re-
corded cause of death from death certificates.
AbStrACt
Objectives To investigate mortality in adults with 
intellectual disabilities: rates, causes, place, demographic 
and clinical predictors.
Design Cohort study with record linkage to death data.
Setting General community.
Participants 961/1023 (94%) adults (16–83 years; 
mean=44.1 years; 54.6% male) with intellectual 
disabilities, clinically examined in 2001–2004; 
subsequently record- linked to their National Health Service 
number, allowing linkage to death certificate data, 2018.
Outcome measures Standardised mortality ratios (SMRs), 
underlying and all contributing causes of death, avoidable 
deaths, place, and demographic and clinical predictors of 
death.
results 294/961 (30.6%) had died; 64/179 (35.8%) 
with Down syndrome, 230/783 (29.4%) without Down 
syndrome. SMR overall=2.24 (1.98, 2.49); Down 
syndrome adults=5.28 (3.98, 6.57), adults without Down 
syndrome=1.93 (1.68, 2.18); male=1.69 (1.42, 1.95), 
female=3.48 (2.90, 4.06). SMRs decreased as age 
increased. More severe intellectual disabilities increased 
SMR, but ability was not retained in the multivariable 
model. SMRs were higher for most International Statistical 
Classification of Diseases and Related Health Problems, 
10th Revision chapters. For adults without Down 
syndrome, aspiration/reflux/choking and respiratory 
infection were the the most common underlying causes 
of mortality; for Down syndrome adults ‘Down syndrome’, 
and dementia were most common. Amenable deaths 
(29.8%) were double that in the general population 
(14%); 60.3% died in hospital. Mortality risk related to 
percutaneous endoscopic gastrostomy/tube fed, Down 
syndrome, diabetes, lower respiratory tract infection at 
cohort- entry, smoking, epilepsy, hearing impairment, 
increasing number of prescribed drugs, increasing age. 
Bowel incontinence reduced mortality risk.
Conclusions Adults with intellectual disabilities with and 
without Down syndrome have different SMRs and causes 
of death which should be separately reported. Both die 
younger, from different causes than other people. Some 
mortality risks are similar to other people, with earlier 
mortality reflecting more multimorbidity; amenable deaths 
are also common. This should inform actions to reduce 
early mortality, for example, training to avoid aspiration/
choking, pain identification to address problems before 
they are advanced, and reasonable adjustments to improve 
healthcare quality.
IntrODuCtIOn
People with intellectual disabilities die at a 
younger age than other people; on average, 
20 years younger,1 or 28 years younger specif-
ically for people with Down syndrome.2 It has 
been demonstrated that people with intel-
lectual disabilities receive poorer manage-
ment of their long- term conditions within 
primary healthcare services compared with 
the general population,3 and it is conceiv-
able that this is one contributor to earlier 
mortality. It has been suggested that as many 
as 40% of deaths of people with intellec-
tual disabilities may have been amenable to 
good quality healthcare.4–6 There has been 
a recent increase in research on mortality in 
people with intellectual disabilities, but very 
little research has distinguished people with 
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intellectual disabilities with and without Down syndrome, 
or investigated the factors associated with risk of mortality, 
and causes of mortality.
Previous studies on death in people with intellectual 
disabilities had limitations such as small sample sizes, 
or non- representative populations. More recently, there 
have been large- scale studies which are more represen-
tative, having been drawn from intellectual disabilities 
registers, or social security or primary care data with 
record linkage to death certification. These have been 
undertaken in parts of Sweden, Australia, England, 
Finland, Canada, Ireland and USA(online supplementary 
table 1).5–19 These studies fairly consistently report stan-
dardised mortality ratios (SMRs) to be high for people 
with intellectual disabilities, more so at younger ages and 
higher for women than men. Adult studies have tended to 
report SMRs in the region of 2–4, although in some, SMR 
is only slightly above 1.10 16 19 However, direct comparison 
between studies is not always possible, due to the different 
age ranges studied and methods of reporting.
In view of the methods that studies have used for popu-
lation identification (typically, routine administrative 
data linked to death certifications), they provide little 
information on the socioclinical factors that influence 
SMR, or the risk factors associated with death, beyond 
that of age and sex. Three studies reported SMR by level 
of intellectual disabilities, with, broadly speaking, higher 
SMR with more severe intellectual disabilities.7 10 17 Only 
three studies (different studies to those that reported on 
level of intellectual disabilities) were able to report data 
separately for adults with intellectual disabilities with and 
without Down syndrome; two found higher mortality 
rates for adults with Down syndrome (SMR=7.69 and 
HR=9.215) than for adults without Down syndrome, or 
an OR showing Down syndrome as a risk of death.12A 
further study reported SMR=5.5 for children and adults 
(combined) with Down syndrome, but did not report 
SMR for those with intellectual disabilities without Down 
syndrome.20 Two studies reported adults with intellectual 
disabilities to have higher SMRs if they have the comorbid-
ities of epilepsy,5 7 and cerebral palsy,7 as opposed to not 
having these comorbidities. One study reported adults 
with intellectual disabilities with comorbid autism to 
have lower risk of mortality than those without comorbid 
autism.5 One study reported the risk factors for mortality 
in a population with intellectual disabilities to be age, 
Down syndrome, cerebral palsy, blindness/low vision, 
technological dependence/medical fragility, wheelchair 
dependence, mobility impairment without wheelchair 
dependence, and epilepsy.12 Factors not found to be risks, 
if any, were not reported, and a further limitation was 
that factors were reported by agency staff, rather than the 
individuals undergoing health assessments.12 We have not 
identified any other studies that investigated risk factors 
for time to mortality in adults with intellectual disabilities.
There is less consistency regarding the most common 
certified underlying causes of death in adults with intel-
lectual disabilities, partly as some studies do not report 
these separately for children and adults, or by age ranges. 
Additionally, studies group causes of death in different 
ways (eg, pneumonia vs respiratory system), which 
can affect prevalence rankings between studies. Pneu-
monia, other respiratory diseases and diseases of the 
nervous system were reported to be the most common 
in one study,11 diseases of the circulatory system and 
respiratory systems in another,5 heart disease, neoplasm 
and Alzheimer disease in a third,18 and diseases of the 
circulatory system, neoplasm and the nervous system in 
a fourth.19 In adults with intellectual disabilities, cause- 
specific SMRs have been reported to be high across most 
groups of disorders.5 11 These studies did not report cause 
of death separately for adults with and without Down 
syndrome. Given the different health profile of people 
with Down syndrome compared with people with intel-
lectual disabilities of other causes, this is an important 
limitation.21 In people with Down syndrome, most studies 
on mortality have been conducted with child popula-
tions, and report the most common causes of death to be 
congenital heart disease, and pneumonia/diseases of the 
respiratory system.2
Overall, the existing body of literature on mortality in 
adults with intellectual disabilities does not include more 
detailed information on level of intellectual disabilities, 
nor separate out the population with, from those without, 
Down syndrome (for whom causes of death may differ), 
nor investigate health and demographic predictors of 
death other than age and sex, and is inconsistent with 
regard to causes of death. A better understanding of 
these factors may provide a pathway to action to reduce 
the observed earlier mortality in adults with intellectual 
disabilities.
This study aims to investigate the rates, causes, place 
and demographic and clinical associations with mortality 
in adults with intellectual disabilities, with and without 
Down syndrome.
MethODS
Participants
The adult (aged 16+ years) intellectual disabilities popu-
lation living within the NHS Greater Glasgow area was 
identified through multiple sources between 2000 and 
2001. General practitioners were financially incentiv-
ised to identify their registered patients with intellectual 
disabilities, and all 631 (100%) did so. Adults were also 
identified via the intellectual disabilities health and social 
work services including day services, the Health Board 
register and records of financial payments for any service 
by social work. This process led initially to an overidenti-
fication, such as people with IQ scores in the 70–80 range 
with additional complex health needs. All were system-
atically reviewed by nurses in the intellectual disabilities 
health service, and this group were removed. Thus, a 
register was compiled, and subsequently updated annu-
ally via general practices, with central support from the 
intellectual disabilities health service, until 2017 when 
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services were redesigned. The identified adult prevalence 
of intellectual disabilities within the area was 3.33 per 
1000 in 2000–2001.
Process and data collection
With initial piloting in 2001, each participant had a 
detailed assessment of their general and mental health, 
and demographic factors, completed 2002–2004. One of 
the six specially trained, registered nurses reviewed each 
person’s primary health care records, then used a semi-
structured tool, the C21st Health Check, to assess clinical 
factors and the level and cause of intellectual disabili-
ties. In addition to a review of existing health problems 
and all bodily health systems, a physical examination was 
undertaken, including assessment of vision and hearing, 
measurement of height and weight and a phlebotomy 
protocol followed. All information was then reviewed by 
the nurse with one of three general practitioners with a 
special interest in intellectual disabilities, and any further 
investigations that were indicated were completed. Previ-
ously known, and newly identified, conditions were then 
classified using the International Statistical Classification 
of Diseases and Related Health Problems, 10th Revision (ICD-
10).22 Anyone identified to have possible, probable or 
definite mental ill- health, autism or problem behaviours 
was then fully assessed by the project’s intellectual disabil-
ities psychiatrists. Each person’s assessment findings were 
then case conferenced by the two Consultant psychiatrists, 
and diagnoses were derived and agreed according to clin-
ical diagnoses, ICD-10 (Diagnostic Criteria for Research),23 
Diagnostic and Statistical Manuel of Mental Disorders- IV- TR24 
and Diagnostic Criteria for Psychiatric Disorders for use with 
Adults with Learning Disabilities.25 Information was also 
collected on demographics, and community, hospital, 
and social service use. Further details are provided else-
where.26 27 The data were entered into a database by two 
dedicated data- entry staff.
Each person in Scotland is given a number unique to 
them at birth or first registration with a general practi-
tioner, which is used in almost all subsequent health 
service encounters, and on certification of death. The 
numbers are held on the Community Health Index 
(CHI) database at National Services Scotland. These CHI 
numbers provided a means to record link each partici-
pant with National Records for Scotland death certi-
fication data. This linkage was performed in 2018, and 
the linked data were held in the NHS Greater Glasgow 
& Clyde (NHS GG&C) Safe Haven. Data on immediate, 
underlying and contributory causes of deaths by ICD-10 
codes, age at death and place of death were extracted.
In order to provide finer granularity of cause of death, 
two clinical academics then grouped specific causes of 
death into narrower groupings than those provided by 
ICD-10 chapter headings (online supplementary table 
2). This approach was also in view of the recognised 
issue of variation between health staff in distinguishing 
and recording immediate causes of death, and because 
some causes occurred in low numbers so could not be 
individually reported due to the risk of statistical disclo-
sure. Additionally, some conditions likely to be the same 
are spilt between different ICD-10 chapters, for example, 
dementia in Alzheimer disease (F00) and unspecified 
dementia (F03) in the ICD-10 mental and behavioural 
disorders chapter, and Alzheimer’s disease (G30) and 
Alzheimer’s disease, unspecified (G30.9) in the ICD-10 
diseases of the nervous system chapter. A list of related 
conditions was generated by one of the clinical academics 
and then checked by the second.
Analyses
All statistical analyses were conducted using R for Windows 
V.3.3.0 or SAS V.9.3 and were performed within the NHS 
GG&C Safe Haven environment. Due to disclosure prin-
ciples of the Safe Haven, results with counts of less than 
five cannot be released; these have been referred to as <5 
throughout. Similarly, if it is deemed possible that partic-
ipants may be identified from the results, these may be 
omitted. Details are provided if this occurred.
Data were summarised for the population of adults 
aged 16+ years with intellectual disabilities. Categorical 
variables were summarised with the number and percent-
ages of people falling into each category and the number 
of missing data. Continuous variables were summarised 
with the number of observations and those missing, the 
mean and SD, and the minimum and maximum values, 
unless otherwise stated.
Participant characteristics were summarised overall 
and for those alive and those deceased. For those who are 
deceased, their data including age at death, underlying/
contributing causes of death, and location of death were 
summarised for those with and without Down syndrome. 
Location codes for place of death are provided where 
available. We assumed those with the code for non- 
institutional location to have died at home. Due to small 
numbers, location codes have been grouped together for 
NHS hospitals, home, and other hospitals/care facilities 
including hospices.
Mortality incidence rates have been calculated using the 
number of deaths in the cohort divided by the number 
of person years alive within the study period multiplied 
by 100 000, overall and for those with and without Down 
syndrome. SMRs were calculated using population 
data for those aged 15 and over within NHS GG&C in 
2010.28 29 Death rates for males and females by 5- year 
band ages groups spanning from 15 to 20 years old to 90 
years and over were summed to form the expected death 
rates for the general population. The observed death rate 
for adults with intellectual disabilities was taken from our 
study results. The observed/expected death rates were 
calculated for the intellectual disabilities cohort overall 
then separately by age group, sex, ability level, and for 
the adults with and without Down syndrome, and ICD-10 
chapter for cause of death, and compared with the 
general population.
Deaths were also analysed for those that could be 
considered as deaths that would have been avoidable. 
 on June 1, 2020 at B
V
A
. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-036465 on 17 M
ay 2020. D
ow
nloaded from
 
4 Cooper S- A, et al. BMJ Open 2020;10:e036465. doi:10.1136/bmjopen-2019-036465
Open access 
The Office for National Statistics (ONS) published a defi-
nition of avoidable mortality,30 which lists the causes of 
amenable deaths (deaths that should not occur in the 
presence of good healthcare, eg, respiratory disease) and 
causes of preventable deaths (eg, from diseases that could 
have been avoided by prior immunisation), by ICD-10 
codes. Causes of death for the adults with intellectual 
disabilities have been summarised by ONS definition of 
avoidable deaths.
To determine the demographic and clinical factors asso-
ciated with death in adults with intellectual disabilities, 
time to event analyses were explored using univariate Cox 
Proportional Hazards models. Variables were selected 
as potentially relevant on the basis of what is known on 
causes of death in people with intellectual disabilities, the 
20 most common physical health conditions reported in 
the adult population with intellectual disabilities,21 and 
other factors hypothesised as potentially clinically rele-
vant (online supplementary table 3):
 ► Demographics—nine variables.
 ► Clinical conditions—33 variables.
 ► Service use—three variables.
 ► Prescriptions—five variables.
All 50 variables were then permitted entry in to a single 
multivariable analysis using stepwise regression methods, 
in order to identify a model containing the statistically 
significant factors associated with death. Age at date of the 
health assessment was entered into the model as a contin-
uous measure. Results from the univariate Cox Propor-
tional Hazards models (online supplementary table 3) 
and the statistically significant multivariable model from 
the stepwise results have been presented with HRs with 
corresponding 95% CIs (HR, 95% CI) and p- values were 
obtained.
Patient and public involvement
This study was designed to respond to the growing 
concern expressed by people with intellectual disabilities, 
their families and third sector organisations about the 
early deaths of people with intellectual disabilities. The 
Scottish Learning Disabilities Observatory, where this 
research was undertaken, has a specific remit for people 
with intellectual disabilities. Its steering group includes 
partners from third sector organisations, including Down 
syndrome Scotland, and people with intellectual disabili-
ties, who approved the work plan for this project prior to it 
commencing. Results from this study will be disseminated 
for people with intellectual disabilities in an easy- read 
version via the Scottish Learning Disabilities Observatory.
reSultS
Population characteristics
Of note, 962 of the original 1023 (94.0%) adults with 
intellectual disabilities who were assessed were linked to 
a CHI number enabling the extraction of relevant death 
data. Reasons for the unlinked 61 people could be due 
to moving out of the area, or a recording mistake. One 
further participant was removed from the analysis due to 
inaccurate recording of dates, leaving 961 adults in the 
cohort (93.9%). Of these 961 adults, 294 (30.6%) had a 
record of death. Table 1 shows the baseline characteristics 
of the full cohort of 961, the adults who died and those 
still alive at the time of linkage.
Age at death and mortality incidence
The mean age at death was 61.0 years (SD=7.0 years). Of 
the 961 adults, 64 (35.8%) of the 179 adults with Down 
syndrome and 230 (29.4%) of the 782 adults without 
Down syndrome had a record of death. Their mean age 
of death was 56.9 years (SD=4.3 years) for the adults with 
Down syndrome, and 62.2 years (SD=7.5 years) for the 
adults without Down syndrome. Mortality incidence for 
the cohort during the study period was 3049.0 per 100 000 
person years follow- up, with 3832.1 per 100 000 for those 
with Down Syndrome and 2885.0 for those without Down 
syndrome.
Standardised mortality ratios
Compared with the general population, the SMR was 2.24 
(1.98, 2.49) overall; 5.28 (3.98, 6.57) for adults with Down 
syndrome, 1.93 (1.68, 2.18) for adults without Down 
syndrome; 1.69 (1.42, 1.95) for men and 3.48 (2.90, 4.06) 
for women. SMRs were higher the more severe the level 
of intellectual disabilities, with people with profound 
intellectual disabilities having an SMR of 4.14 (3.11, 
5.17). SMR was high for all age groups (though for the 
15–25 year age group, the wide CI includes one, perhaps 
due to the smaller number of deaths in this group); this 
decreased as age increased. SMRs were high for most 
ICD-10 chapter groups of conditions, particularly so for 
congenital malformations at 17.26 (10.75, 23.78), diseases 
of the digestive system at 16.13 (8.23, 24.04), mental and 
behavioural disorders at 12.64 (3.27, 22.00) and external 
causes at 11.08 (3.40, 18.76). Details are shown in table 2.
Causes of death
Cause of death data was available from death certificates 
for 262 (89.1%) of 294 participants who had died, which 
include 57 (89.1%) participants with Down syndrome, 
and 205 (88.7%) participants without Down syndrome. 
Table 3 shows the underlying causes of death by ICD-10 
chapters separately for the adults with and without 
Down syndrome. For the whole cohort, diseases of the 
respiratory system were the most common (21.8%), 
then diseases of the circulatory system (19.1%), then 
diseases of the nervous system (13.0%) and neoplasms, 
followed by congenital anomalies (10.3%). For the adults 
with Down syndrome, congenital anomalies were the 
most common (in all cases this was a record of ‘Down 
syndrome’), then jointly diseases of the respiratory system 
and diseases of the circulatory system, then diseases of 
the nervous system, followed by infections, and mental 
and behavioural disorders. For the adults without Down 
syndrome, diseases of the respiratory system were the 
most common, then diseases of the circulatory system, 
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Table 1 Cohort characteristics at time of the health assessment, summarised overall and by death status during the follow- up 
period
Variable Statistics/groups
All participants
(n=961)
Deceased participants
(n=294)
Alive participants
(n=667)
Age (years) Mean (SD) 44.1 (14.6) 52.4 (13.6) 40.5 (13.6)
Min, max 16–83 18–83 16–77
Age group 16–25 years 127 (13.2%) 10 (3.4%) 117 (17.5%)
26–35 years 153 (15.9%) 26 (8.8%) 127 (19.0%)
36–45 years 246 (25.6%) 49 (16.7%) 197 (29.5)
46–55 years 205 (21.3%) 85 (28.8%) 120 (18.0%)
>55 years 230 (23.9%) 124 (42.0%) 106 (15.9%)
Sex Male 525 (54.6%) 154 (52.4%) 371 (55.6%)
Female 436 (45.3%) 140 (47.5%) 296 (44.4%)
Ability level Mild ID 382 (39.7%) 92 (31.2%) 290 (43.5%)
Moderate ID 236 (24.5%) 73 (24.7%) 163 (24.4%)
Severe ID 180 (18.7%) 67 (22.7%) 113 (16.9%)
Profound ID 163 (17.0%) 62 (21.1%) 101 (15.1%)
Accommodation type Family carer 374 (38.9%) 70 (23.8%) 304 (45.6%)
Independent 93 (9.7%) 36 (12.2%) 57 (8.5%)
Paid support 435 (45.2%) 161 (54.6%) 274 (41.1%)
Congregate care 59 (6.1%) 27 (9.2%) 32 (4.8%)
Down syndrome No 782 (81.4%) 230 (78.2%) 552 (82.8%)
Yes 179 (18.6%) 64 (21.7%) 115 (17.2%)
ID, intellectual disabilities.
then neoplasms, then diseases of the nervous system, 
followed by diseases of the digestive system. Table 4 
presents the most common underlying causes of death 
by individual causes, or related groups of causes, with 
finer granularity than ICD-10 chapter headings (groups 
are shown in online supplementary table 2). Causes are 
listed in the order of how common they were in the whole 
cohort. Data are presented separately for the adults with 
and without Down syndrome. For the whole cohort, the 
most common cause was aspiration/reflux/choking, 
then respiratory infection, then other malignancy (non- 
gastrointestinal), then other condition (mostly unrelated 
conditions that could not be reported individually or as 
groups, due to individually occurring at a frequency of 
<5). For the adults with Down syndrome, Down syndrome 
was the most common cause, then dementia, then other 
infection. For the adults without Down syndrome, aspi-
ration/reflux/choking was the most common cause, 
then respiratory infection, then other malignancy (non- 
gastrointestinal). For the 21 people whose death certifi-
cate listed Down syndrome as their underlying cause of 
death, the death certificates were reviewed and under-
lying cause of death reclassified, as a sensitivity check. 
Following this, the most common underlying causes of 
death for the adults with Down syndrome were dementia 
(n=20; 35.1%), then other infection (n=7; 12.3%).
Table 5 shows the all contributing causes of death data, 
again presenting the most common causes by individual 
causes, or related groups of causes with finer granularity 
than ICD-10 chapter headings. Data are presented sepa-
rately for the adults with and without Down syndrome. 
For the whole cohort, respiratory infection was the most 
common cause (27.1%), followed by aspiration/reflux/
choking (19.8%), other conditions (15.6%), other cardio-
vascular conditions (non- acute myocardial nor other 
ischaemic heart disease: 14.5%), then other respiratory 
conditions. For the adults with Down syndrome, Down 
syndrome was the most common, then dementia, then 
respiratory infection, then aspiration/reflux/choking. 
For the adults without Down syndrome, respiratory 
infection was the most common cause, then aspiration/
reflux/choking, then other condition, then other respira-
tory conditions and intellectual disabilities.
Avoidable deaths
According to the ONS list of avoidable deaths, 102 
(38.9%) of the 262 deaths were avoidable; most notably, 
respiratory infection and epilepsies (table 4); 78 (29.8%) 
were deaths that are amenable to good healthcare, while 
51 (19.5%) were preventable deaths, and 27 (10.3%) 
deaths were classed as both amenable and preventable 
deaths. This compares to published Scottish death data 
showing in 2018 that 28% of deaths were avoidable; 14% 
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Table 2 Standardised mortality ratios
Variable Groups SMR (95% CI)
All participants – 2.24 (1.99 to 2.50)
Age group* 15–25 years 18.73 (0.37 to 37.09)
26–35 years 4.21 (1.29 to 7.13)
36–45 years 3.86 (2.28 to 5.44)
46–55 years 3.77 (2.90 to 4.74)
>55 years 1.86 (1.60 to 2.12)
Sex Male 1.69 (1.42 to 1.95)
Female 3.48 (2.90 to 4.06)
Ability level Mild ID 1.60 (1.27 to 1.92)
Moderate ID 2.10 (1.62 to 2.58)
Severe ID 2.78 (2.11 to 3.44)
Profound ID 4.14 (3.11 to 5.17)
Down syndrome No 1.93 (1.68 to 2.18)
Yes 5.28 (3.98 to 6.57)
Underlying causes of death 
grouped by ICD-10 chapter†
Congenital malformations, deformations and chromosomal 
abnormalities
17.26 (10.75 to 23.78)
Diseases of the blood and blood- forming organs and certain disorders 
involving the immune mechanism
7.50 (-7.20 to 22.20)
Diseases of the circulatory system 5.55 (4.01 to 7.09)
Diseases of the digestive system 16.13 (8.23 to 24.04)
Diseases of the genitourinary system 3.65 (0.73 to 6.57)
Diseases of the musculoskeletal system and connective tissue 5.40 (-0.71 to 11.52)
Diseases of the nervous system 7.73 (5.13 to 10.32)
Diseases of the respiratory system 6.78 (5.02 to 8.54)
Diseases of the skin and subcutaneous tissue 2.75 (−2.64 to 8.15)
Endocrine, nutritional and metabolic diseases 3.43 (1.05 to 5.81)
External causes of morbidity and mobility 11.08 (3.40 to 18.76)
Infectious and parasitic diseases 8.93 (1.78 to 16.07)
Mental and behavioural disorders 12.64 (3.27 to 22.00)
Neoplasms 6.31 (4.19 to 8.43)
Symptoms, signs and abnormal clinical and laboratory findings, not 
elsewhere classified
19.51 (0.39 to 38.63)
*Data used for comparison with General Population (GG&C Health Board) provide data in 5- year age bands therefore 15+. 
Data on adults with ID are 16+.
†Negative Lower CI and wide CIs indicate low number of observed deaths in study population.
ICD-10, International Statistical Classification of Diseases and Related Health Problems, 10th Revision; ID, intellectual 
disabilities; SMR, standardised mortality ratios.
amenable, and 24% preventable, similar to the figures in 
the previous 4 years (data not available prior to 2014).31 
For the 57 deaths of adults with Down syndrome, 17 
(29.8%) deaths were avoidable, 15 (26.3%) deaths were 
amenable to good healthcare, while seven (12.3%) were 
preventable, and five (8.8%) were both amenable and 
preventable. For the 205 deaths of adults without Down 
syndrome, 85 (41.5%) were avoidable, 63 (30.7%) deaths 
were amenable to good healthcare, while 44 (21.5%) 
were preventable, and 22 (10.7%) were both amenable 
and preventable.
Place of death
Of the 262 participants for whom place of death was known, 
158 (60.3%) died in an NHS Hospital, 70 (26.7%) died at 
home, and 34 (13.0%) died within other hospitals/care 
facilities. This was similar for both the adults with Down 
syndrome: 31 (54.4%) in an NHS hospital, 17 (29.8%) 
at home, and nine (15.8%) within other hospitals/care 
facilities; and the adults without Down syndrome: 127 
(62.0%) in an NHS hospital, 53 (25.9%) at home, and 25 
(12.2%) within other hospitals/care facilities.
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Table 3 Underlying causes of death grouped by ICD-10 
chapter, where cause of death is known
ICD-10 chapter
Participants 
with Down 
syndrome
(n=57)
Participants 
without 
Down 
syndrome
(n=205)
Certain infectious and parasitic 
diseases
5 (8.8%) <5
Neoplasms <5 33 (16.1%)
Diseases of the blood and 
blood- forming organs and 
certain disorders involving the 
immune mechanism
<5 <5
Endocrine, nutritional and 
metabolic diseases
<5 8 (3.9%)
Mental and behavioural 
disorders
5 (8.8%) <5
Diseases of the nervous system 7 (12.3%) 27 (13.2%)
Diseases of the eye and adnexa <5 <5
Diseases of the ear and mastoid 
process
<5 <5
Diseases of the circulatory 
system
8 (14.0%) 42 (20.5%)
Diseases of the respiratory 
system
8 (14.0%) 49 (23.9%)
Diseases of the digestive 
system
<5 16 (7.8%)
Diseases of the skin and 
subcutaneous tissue
<5 <5
Diseases of the musculoskeletal 
system and connective tissue
<5 <5
Diseases of the genitourinary 
system
<5 5 (2.4%)
Pregnancy, childbirth and the 
puerperium
<5 <5
Certain conditions originating in 
the perinatal period
<5 <5
Congenital malformations, 
deformations and chromosomal 
abnormalities
21 (36.8%) 6 (2.9%)
Symptoms, signs and abnormal 
clinical and laboratory findings, 
not elsewhere classified
<5 <5
External causes of morbidity 
and mortality
<5 7 (3.4%)
All deaths 57 (100%) 205 (100%)
ICD-10, International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision.
Table 4 Underlying causes of death grouped by specific 
individual causes or related groups of causes, where cause 
of death is known
Causes
Participants 
with Down 
syndrome
(n=57)
Participants 
without Down 
syndrome
(n=205)
Aspiration/reflux/choking <5 22 (10.8%)
Respiratory infection <5 21 (10.3%)
Down syndrome 21 (36.8%) <5
Other malignancy <5 19 (9.3%)
Other condition <5 17 (8.3%)
Epilepsies <5 13 (6.4%)
Acute myocardial 
infarction
<5 13 (6.4%)
Gastrointestinal 
malignancy
<5 12 (5.9%)
Stroke <5 11 (5.4%)
Other cardiovascular 
disease
<5 11 (5.4%)
Other respiratory 
condition
<5 9 (4.4%)
Other infection 5 (8.8%) 6 (2.9%)
Cerebral palsy <5 11 (5.4%)
Dementia 9 (15.8%) <5
Other gastrointestinal 
disorders
<5 8 (3.9%)
Ulcer/gastrointestinal 
perforation
<5 7 (3.4%)
Diabetes <5 7 (3.4%)
Other congenital 
condition
<5 6 (2.9%)
Other ischaemic heart 
condition
<5 6 (2.9)
Mental health <5 <5
Other neurological 
conditions
<5 <5
Renal failure <5 <5
All deaths 57 (100%) 205 (100%)
Factors associated with risk of death
The results from the univariate cox proportional hazards 
models indicated that of the original 50 potential vari-
ables, factors associated with risk of death were (online 
supplementary table 3) as follows:
 ► Demographics–age at the time of the health assess-
ment, more severe learning disabilities, accommo-
dation type (not living with family carer), not having 
day- time occupation, and being a smoker (but not 
sex, the extent of neighbourhood deprivation, civil 
status, nor Down syndrome, in view of the CIs).
 ► Clinical conditions–having spastic quadriplegia, 
hearing impairment, visual impairment, diabetes, 
percutaneous endoscopic gastrostomy/tube fed, 
constipation, ataxia/gait disorder, osteoporosis, hyper-
tension, dysphagia, dyspnoea, gastro- oesophageal 
reflux disorder, lower respiratory tract infection, 
total number of physical health disorders, not having 
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Table 5 All contributing causes of death grouped by 
specific individual causes or related groups of causes, 
where cause of death is known
Causes
Participants 
with Down 
syndrome
(n=57)
Participants 
without Down 
syndrome
(n=205)
Respiratory infection 22 (38.6%) 49 (23.9%)
Aspiration/reflux/choking 11 (19.3%) 41 (20.0%)
Down syndrome 43 (75.4%) <5
Other condition 8 (14.0%) 33 (16.1%)
Other cardiovascular 
disease
8 (14.0%) 30 (14.6%)
Other respiratory conditions <5 31 (15.1%)
Other infection 9 (15.8%) 24 (11.7%)
Intellectual disabilities <5 31 (15.1%)
Epilepsies 8 (14.0%) 24 (11.7%)
Dementia 24 (42.1%) <5
Other neoplasms <5 23 (11.2%)
Cerebral palsy <5 24 (11.7%)
Acute myocardial infarction 5 (8.8%) 19 (9.3%)
Other gastrointestinal 
disorders
<5 18 (8.8%)
Diabetes <5 19 (9.3%)
Other ischaemic heart 
disease
<5 19 (9.3%)
Renal failure <5 16 (7.8%)
Stroke <5 17 (8.3%)
Other congenital condition <5 15 (7.3%)
Gastrointestinal malignant 
neoplasm
<5 12 (5.9%)
Ulcer/gastrointestinal 
perforation
<5 10 (4.9%)
Mental health <5 10 (4.9%)
Other neurological condition <5 8 (3.9%)
Heart failure <5 7 (3.4%)
Injuries and accidents <5 8 (3.9%)
Medical/surgical 
complications
<5 <5
Secondary malignancies <5 <5
Thyroid disorders <5 <5
Metabolic disorder <5 <5
All deaths 57 (100%) 205 (100%)
Table 6 Multivariable model results for the outcome time 
to death
Variable HR 95% CI P
Age at time of health 
assessment
1.056 1.046 to 1.066 <0.0001
Smoker
  No 1 –
  Yes 1.531 1.1011 to 2.128 0.0112
Down syndrome
  No 1 –
  Yes 2.44 1.787 to 3.332 <0.0001
Epilepsy
  No 1 –
  Yes 1.511 1.173 to 1.946 0.0014
Hearing impairment
  No 1 –
  Yes 1.32 1.030 to 1.692 0.0284
Bowel incontinence
  No 1 –
  Yes 0.49 0.376 to 0.640 <0.0001
Diabetes
  No 1 –
  Yes 2.346 1.553 to 3.542 <0.0001
PEG/tube fed
  No 1 –
  Yes 2.346 1.135 to 5.989 0.0024
Lower respiratory track infection
  No 1 –
  Yes 1.782 1.315 to 2.415 0.0002
Total number of 
prescribed drugs
1.066 1.016 to 1.118 0.0085
PEG, percutaneous endoscopic gastrostomy.
impaired mobility, not having urinary incontinence, 
not having bowel incontinence, and not having autism 
(but not epilepsy, body mass index, nail disorder, 
epidermal thickening, cerebral palsy, fungal infec-
tion, musculoskeletal pain, bone deformity, dental/
oral problem, eczema/dermatitis, psychosis, affective 
disorder including bipolar affective disorder, problem 
behaviour, eating disorder including pica, nor any 
mental illness).
 ► Service use—number of general practitioner consul-
tations in the previous 12 months, total number of 
different types of health professionals providing 
care at the time of the clinical assessment (but not 
number of accident and emergency attendances in 
the previous 12 months).
 ► Prescriptions—antiepileptic drugs, total number of 
different types of drugs (but not antipsychotic drugs, 
antidepressant drugs, nor anxiolytic drugs).
Table 6 shows the final model of the variables retained 
in the multivariable analysis for time to death. The 
significant factors indicating an increased risk of death 
were increased age at the time of the health assessment, 
smoking, Down syndrome, diabetes, being percutaneous 
endoscopic gastrostomy/tube fed, lower respiratory 
tract infection at cohort inception, epilepsy, hearing 
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impairment, and total number of different types of 
drugs prescribed, while bowel incontinence showed a 
reduced risk of death. Of note, level of intellectual disa-
bilities, while significant in the univariate analysis, was not 
retained in the multivariable model.
DISCuSSIOn
Principle findings and interpretation
As far as we are aware, this is the first population- based 
study of adults with intellectual disabilities to report in 
detail the factors associated with time to death, and to 
describe their causes of death, and quantify the SMR 
separately for adults with and without Down syndrome. 
This is important, since adults with Down syndrome 
form a notable proportion of all adults with intellectual 
disabilities (19% in this cohort), and because they have 
a different pattern of clinical conditions compared with 
other adults with intellectual disabilities.21 We found that 
aspiration/reflux/choking is the most common under-
lying cause of death in adults with intellectual disabilities, 
followed by respiratory infection. They are also the most 
common all contributing causes of death. The profile 
differed in the adults with Down syndrome for whom 
‘Down syndrome’, followed by dementia, were recorded 
as the most common underlying cause of death, and all 
contributing causes of death (or alternatively, dementia, 
then other infection were the most common underlying 
causes when ‘Down syndrome’ deaths were reclassi-
fied); with the next most common all contributing cause 
of death being respiratory infection, then aspiration/
reflux/choking. The proportion of deaths that would 
have been amenable to good care for adults with intel-
lectual disabilities was more than double that seen in the 
general population. Although aspiration/reflux/choking 
is not included in the ONS list of avoidable deaths, 
and therefore not included in the figures we report on 
amenable deaths, we consider that good care also could 
have prevented many of these aspiration/reflux/choking 
deaths. This appears to be very important for adults with 
intellectual disabilities irrespective of whether they have 
Down syndrome. Similarly, some other causes of deaths 
within this cohort (online supplementary table 2), such as 
constipation/mega- colon, and urinary tract infections do 
not appear on the ONS list of avoidable deaths.
Clearly, this pattern of causes of death differs from 
that seen in the general population, in whom the most 
common underlying causes of death are heart disease, 
then dementia, then lung cancer in men, and dementia, 
then heart disease, then stroke in women.32 When all 
cancers are grouped together, in the general population, 
cancer is the leading underlying cause of death in 30% 
of men and 26% of women, compared with this study 
reporting 0% for adults with Down syndrome, and 15.2% 
for adults with intellectual disabilities without Down 
syndrome—presumably as the adults with intellectual 
disabilities are dying younger from other causes, and 
cancers increase with age.
We found an overall SMR of 2.24; 5.28 in the adults with 
Down syndrome and 1.93 for the adults without Down 
syndrome. SMRs were higher for most ICD-10 chapter 
groupings of conditions. It was higher in the women than 
the men, as has been previously reported in most (online 
supplementary table 1), but not all10 19 previous reports. 
The reason for this is unknown; in the general popula-
tion, mortality rates have fallen in recent decades, and 
more so in middle and older aged men than women (ie, 
the sex gap is narrowing at these ages), but we do not 
know what trends over time there have been for people 
with intellectual disabilities. Having intellectual disabili-
ties removes differences in lifespan by sex compared with 
the general population; but sex was not a predictor of 
mortality in our study, so the SMR difference may only be 
because of the difference found in the general popula-
tion by sex. SMRs were lowest with older age groups, likely 
to be due to increased illness in the older general popu-
lation and conversely a healthier group with intellectual 
disabilities living to older ages compared with those who 
die younger (as has previously been reported).33 Although 
SMR was higher with increasing severity of intellectual 
disabilities, ability level was not retained within the multi-
variable model on time to death. The factors that were 
independently associated with increased risk of death, in 
order, were being percutaneous endoscopic gastrostomy/
tube fed, Down syndrome, diabetes, having a lower respi-
ratory tract infection at entry to the cohort, smoking, 
epilepsy, hearing impairment, total number of prescribed 
drugs and age, while bowel incontinence had a reduced 
risk of death. Some of these predictors are similar to 
those reported in the general population, suggesting that 
earlier mortality of adults with intellectual disabilities is 
largely accounted for by the higher rates of multimorbid-
ities that they experience compared with other people, 
and amenable deaths.34
While accommodation type (not living with a family 
carer), ability level, not having day- time occupation, 
having spastic quadriplegia, visual impairment, consti-
pation, ataxia/gait disorder, osteoporosis, hypertension, 
dysphagia, dyspnoea, gastro- oesophageal reflux disorder, 
total number of physical health disorders, not having 
impaired mobility, not having urinary incontinence 
and not having autism, number of general practitioner 
consultations in the previous 12 months, total number of 
different types of health professionals providing care at 
the time of the health assessment and antiepileptic drugs 
were related to time of death on univariate analyses, they 
were not retained in the multivariable model.
The majority of the adults with intellectual disabili-
ties, with and without Down syndrome, died in an NHS 
hospital.
Comparison with previous literature
The overall SMR we report, higher SMR in women than 
men and higher SMR at younger age groups is similar 
to the majority of previous reports. Most mortality 
studies with people with Down syndrome have been 
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conducted with children. Previous reports of children 
and adults (combined) gave an SMR=5.5,20 and for adults 
SMR=7.6,9 compared with our finding for adults with 
Down syndrome of SMR=5.28. Recent systematic reviews 
reported people with intellectual disabilities on average 
died 20 years younger than other people, and people 
with Down syndrome died 28 years younger, although the 
majority of the Down syndrome studies were not recent.1 2 
In our study, we found the gap between the age at death 
of people with intellectual disabilities with and without 
Down syndrome to be only 5.3 years, possibly reflecting 
the increasing lifespan of people with Down syndrome 
exceeding increases in lifespan for people with intellec-
tual disabilities without Down syndrome. Notably, after 
‘Down syndrome’, dementia was the most commonly 
reported underlying, and all contributing cause of death 
for the adults with Down syndrome, whereas studies in 
the past commented on congenital heart disease and 
respiratory causes.
For the cohort overall, respiratory infection and 
aspiration/reflux/choking were the most common all 
contributing causes of death. These conditions feature 
in previous studies on causes of death,5 6 8 10 11 although 
there are inconsistencies between studies. By ICD-10 
chapter, our study found the most common underlying 
causes of death were diseases of the respiratory system, 
then of the circulatory system, followed by neoplasms. 
Others reported the most common to be vascular,10 
circulatory,5 heart disease17 and jointly circulatory and 
neoplasm.19
Previous research from other countries has highlighted 
that listing Down syndrome or intellectual disabilities as 
the underlying cause of death obscures actual causes of 
death for this population.35 We therefore presented data 
on revised cause of death for the 21 people for whom it 
was listed as Down syndrome (as a sensitivity check), and 
highlight with interest that in this Scottish cohort, no one 
had intellectual disabilities listed as underlying cause of 
death. This may reflect different medical death certifi-
cate recording practices in Scotland compared with for 
example, the USA.
Studies that investigated avoidable deaths in adults 
with intellectual disabilities found them to be more 
common than in the general population, due to deaths 
that would have been amenable to good care. Avoidable 
deaths have been reported in 44.7% of deaths of people 
with intellectual disabilities in England (mostly amenable 
deaths—figure not reported),6 and in 31% in Australia,19 
compared with our figure of 38.9%. Avoidable deaths 
that would have been amenable to good care have been 
reported to occur in 37% of deaths of people with intel-
lectual disabilities in England.5 Our figure is slightly lower 
at 29.8% but still more than double that found in the 
Scottish general population.31 It should be noted that the 
ONS list of avoidable deaths was not designed specifically 
for people with intellectual disabilities, and it may empha-
sise some causes less relevant, and omit others that might 
be highly relevant in this population.5
Strengths and limitations
The strengths of the study include the thorough methods 
of case ascertainment for intellectual disabilities at base-
line with verification of intellectual disabilities and its 
severity, suggesting results are generalisable in other high- 
income countries. While our identification of the popu-
lation will not have identified everyone with intellectual 
impairment (an IQ<70), in view of the multiple sources 
used we believe it will have identified the adults with intel-
lectual disabilities (IQ<70, plus need for support in daily 
activities, and onset in the developmental period). Addi-
tionally, there were detailed clinical assessments at base-
line, and a longitudinal design. The size of the cohort 
and the duration of follow- up is also a strength, as is the 
successful record linkage for 94% of participants. Our 
study does have limitations, specifically that the study was 
only conducted in one region of Scotland, and the reli-
ance on death certificate data to obtain cause of death. 
Additionally, the characteristics and health of the partici-
pants was collected in 2002–2004. The health conditions 
we investigated tend to be long- standing or remitting/
relapsing conditions, and psychotropic prescribing also 
once initiated tends to be long- standing in people with 
intellectual disabilities. However, it is possible that extent 
of neighbourhood deprivation, type of accommodation, 
employment and civil status (though few marry) might 
have changed for some people between 2002 and 2004 
and 2018; we have no further information to check 
this. There were no concerns regarding the propor-
tional hazards assumption in the multivariable model. 
The linkage was also reliant on the accuracy of the CHI 
number as a sole source of linkage.
Implications
It is important to know the factors that are associated 
with risk of death, and the common causes of death in 
this population, as these then inform the actions needed 
to reduce the unacceptably high SMRs experienced by 
people with intellectual disabilities. Awareness of these 
factors may provide a pathway to action to reduce the 
observed earlier mortality in adults with intellectual 
disabilities. It is not adequate to solely rely on the public 
health interventions available to everyone, even when 
they are accessible. Aspiration, reflux and choking could, 
and should, be avoided by raising awareness of its conse-
quences (death), and putting in place training on simple 
measures related to feeding, positioning, food consis-
tency, and when to seek health advice from speech and 
language therapy, physiotherapy, nursing, and medical 
advice. Carers need to be aware of how the adults they 
care for express pain, so that conditions such as gastro-
intestinal ulcers are attended to, prior to the extreme 
point of perforation and so treatable conditions such as 
constipation and urinary tract infections are managed 
before they lead to respiratory distress and sepsis. Quality 
of care is important; adults with intellectual disabilities 
need just as good care for their diabetes and epilepsy 
(and other conditions) as the rest of the population, with 
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reasonable adjustments to address accessibility, and acces-
sible smoking cessation programmes.
Future research
Further research on larger samples is needed, particularly 
with regard to replicating and extending our findings on 
the factors that are associated with risk of death, and any 
sex differences in them, so that practitioners can focus on 
actions to improve the life expectancy of adults with intel-
lectual disabilities, with and without Down syndrome.
twitter Angela Henderson @ScotLDO
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